Selected for Microsoft for Startups

iMed Technologies, Inc. (headquartered in Bunkyo-ku, Tokyo; Representative Director and CEO, Kenichi Kono), which develops surgical support AI for endovascular surgery for conditions such as ischemic stroke and subarachnoid hemorrhage, has been selected for Microsoft for Startups, a startup support program offered by Microsoft Corporation (headquartered in Washington, USA).

By being selected for Microsoft for Startups, the Company will leverage technology support from Microsoft, including Azure, to accelerate the development of its deep-learning-based surgical support AI, and aims to pursue joint promotions with Microsoft Japan, announce R&D achievements, and develop new services and broad collaborations with companies that use Azure.

■About Microsoft for Startups Microsoft for Startups is a startup support program offered by Microsoft in over 140 countries worldwide, aimed at connecting startups with new customers and channel partners and building a global ecosystem. Startups selected for the program receive technology support, including Azure, as well as dedicated resources suited for business expansion, leveraging Microsoft’s partner network.

Microsoft for Startups overview https://www.microsoft.com/ja-jp/biz/startups/default.aspx

■iMed Technologies, Inc. Company Profile To realize safe surgery for ischemic stroke and subarachnoid hemorrhage, the Company develops surgical support AI leveraging deep-learning-based video analysis, aiming to provide safe and reassuring surgery to patients worldwide.

Company name: iMed Technologies, Inc. Address: 2F Rune Yushima Building, 4-1-13 Yushima, Bunkyo-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for endovascular surgery Representative: Representative Director and CEO, physician Kenichi Kono